Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's DiseaseNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

阿尔茨海默病（Alzheimer’s disease, AD）作为老年人群中最常见的神经退行性疾病，其特征性病理包括 β- 淀粉样蛋白（Aβ）斑块沉积、神经原纤维缠结以及进行性认知功能衰退。尽管流行病学研究早已指出高脂饮食（High-Fat Diet, HFD）诱导的肥胖是 AD 的风险因素，但其中的分子机制一直未被充分阐明。小胶质细胞作为大脑的固有免疫细胞，在 AD ...

Sex-based differences in microglia could help explain patterns in brain diseases. For example, Alzheimer’s affects more women ...

CAR-T cell therapy, a revolutionary cancer treatment, is now under scrutiny due to potential cognitive complications like ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients.All patients experienced stabilization of Expanded Disability ...

People who carry a high genetic risk for alcohol use disorder may have brain immune cells that respond differently to alcohol exposure, according to new research published in Science Advances. Using ...

An international study led by the Institut de Neurociències at the UAB (INc-UAB) has shown that increasing levels of the ...

The research demonstrates that IC 100 blocks microglial inflammasome activation and reduces neurotoxic alpha-synuclein accumulation—both key contributors to PD progression. “These are the ...